Phosphoinositide 3-kinase-δ inhibitor reduces vascular permeability in a murine model of asthma
- 31 August 2006
- journal article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 118 (2), 403-409
- https://doi.org/10.1016/j.jaci.2006.04.041
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Airway smooth muscle: A modulator of airway remodeling in asthmaJournal of Allergy and Clinical Immunology, 2005
- A Prodrug of Cysteine, l-2-Oxothiazolidine-4-carboxylic Acid, Regulates Vascular Permeability by Reducing Vascular Endothelial Growth Factor Expression in AsthmaMolecular Pharmacology, 2005
- PPAR‐gamma modulates allergic inflammation through up‐regulation of PTENThe FASEB Journal, 2005
- Cysteinyl leukotriene receptor antagonist regulates vascular permeability by reducing vascular endothelial growth factor expressionJournal of Allergy and Clinical Immunology, 2004
- Selective role of PI3Kδ in neutrophil inflammatory responsesBiochemical and Biophysical Research Communications, 2003
- Airway remodeling in asthma: New insightsJournal of Allergy and Clinical Immunology, 2003
- Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjectsThorax, 2001
- Regulation of Mammalian O2Homeostasis by Hypoxia-Inducible Factor 1Annual Review of Cell and Developmental Biology, 1999
- Bronchial vascular congestion and angiogenesisEuropean Respiratory Journal, 1997
- Mechanism of Platelet Activating Factor-Induced Vascular Leakage in the Rat TracheaExperimental Lung Research, 1992